# Krystal Biotech, Inc.: Form 8-K, filed Apr 28, 2025

- Company: [Krystal Biotech, Inc.](/companies/krys.md) (CIK 1711279)
- Form: 8-K
- Filed: 2025-04-28
- Accepted by EDGAR: Apr 28, 2025, 08:53 ET
- Period: 2025-04-28
- Accession: 0001711279-25-000029
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1711279/000171127925000029/krys-20250428.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1711279/000171127925000029/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1711279/000171127925000029/krys-20250428.htm

Filed Apr 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001711279-25-000029. Last ingested by Listed: Nov 2, 2026, 07:08 ET. No prices; not investment advice.